Corcept Therapeutics (CORT) Return on Equity [ROE] (2011 - 2026)
Corcept Therapeutics (CORT) recorded Return on Equity [ROE] of 21.09% in Q3 2026, up 4.34 percentage points from 16.75% a year earlier and up 12.87 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Corcept Therapeutics reported Return on Equity [ROE] of 15.01%, down 8.79 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -8.69 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at 23.81% in FY2024 (+2.76 pp), 21.05% in FY2023 (-2.06 pp), 23.11% in FY2022 (-1.92 pp) and 25.03% in FY2021 (+1.32 pp).
- The Q3 2026 figure is the highest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in 1 of the last eight quarters, with an average year-over-year change of -4.63 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 9.29 percentage points in Q1 2022, against a drop of 12.29 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 8.22% (Q2 2026), 7.38% (Q1 2026) and 15.58% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 21.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.09% |
| Jun 30, 2026 | 8.22% |
| Mar 31, 2026 | 7.38% |
| Dec 31, 2025 | 15.58% |
| Sep 30, 2025 | 16.75% |
| Jun 30, 2025 | 20.28% |
| Mar 31, 2025 | 19.67% |
| Dec 31, 2024 | 21.43% |
| Sep 30, 2024 | 22.97% |
| Jun 30, 2024 | 22.03% |
| Mar 31, 2024 | 22.39% |
| Dec 31, 2023 | 21.92% |
| Sep 30, 2023 | 20.68% |
| Jun 30, 2023 | 19.89% |
| Mar 31, 2023 | 18.31% |
| Dec 31, 2022 | 20.78% |
| Sep 30, 2022 | 25.50% |
| Jun 30, 2022 | 26.50% |
| Mar 31, 2022 | 28.53% |
| Dec 31, 2021 | 24.58% |
API Access
Corcept Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();